Life Sciences
The aim is to offer a broader range of personalized treatment options to patients.
The aim of the partnership is to research how AI can help predict cancer progression.
After a clinician prescribes a medication, Connect sends the patient a text message with a link to pharmacies offering the lowest price for the drug.
The company will use the funds to enhance the development of its AI capabilities and for commercial growth.
Vitalchat also garnered $6 million in a Series A round, and Cerula Care secured $3.7 million in an oversubscribed seed funding round.
The alliance will result in the integration of Kyruus Health's care access platform with aha!'s "low-code/no-code" health experience platform.
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.
The bill would allow AI to be classified as a "practitioner licensed by law" to administer FDA-approved drugs.
Everly Health Solutions alleged that Walgreens broke the terms of a 2020 business contract during the COVID-19 pandemic.
The aim of Conduent's Maven is to help epidemiologists detect, monitor, track and report health threats.